Qiagen (QGEN) Misses Q1 EPS by 1c; Reaffirms

Qiagen (NASDAQ: QGEN) reported Q1 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $307.7 million versus the consensus estimate of $306.89 million.

QIAGEN reaffirms full-year 2017 outlook for 6-7% CER sales growth and adjusted EPS target before restructuring costs of $1.25-1.27 CER

For earnings history and earnings-related data on Qiagen (QGEN) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
• RegenLab targets Nasdaq listing under ticker RGNA as revenues top $29 million